Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copanlisib in Relapsed/Refractory Indolent or Aggressive Non-Hodgkin's Lymphoma
NCT01660451Phase 2Completed
- Sponsor
- Bayer
- Start
- Nov 2012
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 25
01
Overview
A Phase 2 trial of copanlisib in non-Hodgkin lymphoma (NHL), sponsored by Bayer. Started Nov 2012; status: completed.
02
Drugs
copanlisib
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01660451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01660451.